{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:14:20Z","timestamp":1786997660643,"version":"build-2736575974"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.transci.2021.103251","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T14:03:39Z","timestamp":1629209019000},"page":"103251","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study"],"prefix":"10.1016","volume":"60","author":[{"given":"Ahmet","family":"Sarici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Ali","family":"Erkurt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irfan","family":"Kuku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Selim","family":"Gok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer Faruk","family":"Bahcecioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soykan","family":"Bicim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilhami","family":"Berber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emin","family":"Kaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Ozgul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2021.103251_bib0005","first-page":"7","article-title":"Cancer statistics, 2016","volume":"66","author":"Siegel","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.transci.2021.103251_bib0010","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1002\/ijc.28849","article-title":"Lymphoid neoplasm incidence by WHO subtype in Australia 1982\u20132006","volume":"135","author":"Van Leeuwen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.transci.2021.103251_bib0015","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2021.103251_bib0020","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","article-title":"A review of autologous stem cell transplantation in lymphoma","volume":"12","author":"Zahid","year":"2017","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.transci.2021.103251_bib0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.3109\/07853890.2014.952662","article-title":"Autologous hematopoietic cell transplantation: an update for clinicians","volume":"46","author":"Hamadani","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/j.transci.2021.103251_bib0030","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.bbmt.2013.10.013","article-title":"Optimizing autologous stem cell mobilization strategies to improve patient outcomes: consensus guidelines and recommendations","volume":"20","author":"Giralt","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.transci.2021.103251_bib0035","first-page":"78","article-title":"Optimizing stem cells mobilization strategies to ameliorate patient outcomes: a review of guide- lines and recommendations","volume":"11","author":"Mohammadi","year":"2017","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.transci.2021.103251_bib0040","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.bbmt.2018.01.007","article-title":"Orchestration of chemomobilization and G-CSF administration for successful hematopoietic stem cell collection","volume":"24","author":"Kriegsmann","year":"2018","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0045","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1056\/NEJM199512073332305","article-title":"Autologous bone marrow transplantation as compared with salvage chemotherapy in relapses of chemotherapy-sensitive non-Hodgkin\u2019s lymphoma","volume":"333","author":"Philip","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/j.transci.2021.103251_bib0050","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.bbmt.2008.07.004","article-title":"Impact of mobilization and remobilization strategies on achieving sufficient stem cell yields for autologous transplantation","volume":"14","author":"Pusic","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0055","doi-asserted-by":"crossref","first-page":"301","DOI":"10.3109\/10428190009065829","article-title":"Is there any difference in PBPC mobilization between cyclophosphamide plus G-CSF and G-CSF alone in patients with non-Hodgkin\u2019s lymphoma?","volume":"39","author":"Dazzi","year":"2000","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.transci.2021.103251_bib0060","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1038\/sj.bmt.1703364","article-title":"Mobilization of peripheral blood stem cells with high-dose cyclophosphamide or the DHAP regimen plus G-CSF in non-Hodgkin\u2019s lymphoma","volume":"29","author":"Pavone","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0065","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1054\/bjoc.1999.0915","article-title":"ESHAP and G-CSF is a superior blood stem cell mobilizing regimen compared to cyclophosphamide 1.5 gm\u2212 2 and G-CSF for pre-treated lymphoma patients: a matched pairs analysis of 78 patients","volume":"82","author":"Watts","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/j.transci.2021.103251_bib0070","doi-asserted-by":"crossref","DOI":"10.7754\/Clin.Lab.2019.190214","article-title":"Comparison of various hematopoietic stem cell mobilization regimens in patients with lymphoma and myeloma","volume":"65","author":"Yilmaz","year":"2019","journal-title":"Clin Lab"},{"key":"10.1016\/j.transci.2021.103251_bib0075","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.transci.2021.103251_bib0080","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/bmt.2016.304","article-title":"A single center\u2019s experience using four different front line mobilization strategies in lymphoma patients planned to undergo autologous hematopoietic cell transplantation","volume":"52","author":"Haverkos","year":"2017","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0085","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1182\/blood.V98.7.2059","article-title":"Randomized trial of filgrastim versus chemotherapy and filgrastim mobilization of hematopoietic progenitor cells for rescue in autologous transplantation","volume":"98","author":"Narayanasami","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.transci.2021.103251_bib0090","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/sj.bmt.1703912","article-title":"G-CSF alone vs cyclophosphamide plus G-CSF in PBPC mobilization of patients with lymphoma: results depend on degree of previous pretreatment","volume":"31","author":"Milone","year":"2003","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0095","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/sj.bmt.1701133","article-title":"CD34+ cells mobilized by cyclophosphamide and granulocyte colony-stimulating factor (G-CSF) are functionally different from CD34+ cells mobilized by G-CSF","volume":"21","author":"Cesana","year":"1998","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.3904\/kjim.2016.163","article-title":"The effect of the dexamethasone, cytarabine, and cisplatin (DHAP) regimen on stem cell mobilization and transplant outcomes of patients with non-Hodgkin\u2019s lymphoma who are candidates for up-front autologous stem cell transplantation","volume":"33","author":"Jeon","year":"2018","journal-title":"Korean J Intern Med"},{"key":"10.1016\/j.transci.2021.103251_bib0105","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/sj.bmt.1704798","article-title":"ESHAP plus G-CSF as an effective peripheral blood progenitor cell mobilization regimen in pretreated non-Hodgkin\u2019s lymphoma: comparison with high-dose cyclophosphamide plus G-CSF","volume":"35","author":"Lee","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.transci.2021.103251_bib0110","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1080\/07357900701788098","article-title":"Comparison of ICE (ifosfamide-carboplatin-etoposide) versus DHAP (cytosine arabinoside-cisplatin-dexamethasone) as salvage chemotherapy in patients with relapsed or refractory lymphoma","volume":"26","author":"Abal\u0131","year":"2008","journal-title":"Cancer Invest"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050221002433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T08:51:40Z","timestamp":1761468700000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050221002433"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S1473050221002433"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2021.103251","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selection of the mobilization regimen in lymphoma patients: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2021.103251","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"103251"}}